COMMUNIQUÉS West-GlobeNewswire

Radient Technologies Inc. Files Provisional Applications for Innovating Cannabis Extraction and Announces Graduation to Tier 1 Issuer Status on the TSX Venture Exchange

29/10/2018 - 12:30

EDMONTON, Alberta, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce that it has filed 18 provisional patent applications with the U.S. [...]

Canada House Wellness Group Provides Update on Production Facility

29/10/2018 - 12:30

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES PICKERING, Ontario, Oct. 29, 2018 (GLOBE NEWSWIRE) -- As product shortages characterized the first week of legal cannabis sales across [...]

Aleafia to Launch Cannabis R&D Division Aleafia Labs

29/10/2018 - 12:16

Patient Data, Intellectual Property to be Used in Development of Proprietary Products TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “Company [...]

Akorn Receives Product Approval

29/10/2018 - 12:05

LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new Abbreviated New Drug [...]

Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials

29/10/2018 - 12:00

BUFFALO, N.Y., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

miRagen Therapeutics to Present at two Investor Conferences in November 2018

29/10/2018 - 12:00

BOULDER, Colo., Oct. 29, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today [...]

Evofuel and Fantini s.r.l Announce Breakthrough in Mechanical Harvesting for Castor Bean

29/10/2018 - 12:00

Mechanical harvesting is a major bottleneck in conversion of castor bean to a fully modernized commercial crop; Combination of Fantini s.r.l Harvester with Evofuel proprietary varieties has demonstrated in field trials [...]

EyePoint Pharmaceuticals Presents Positive YUTIQ™ 24-month Follow-up Data at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting

29/10/2018 - 12:00

WATERTOWN, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results and Recent Highlights

29/10/2018 - 12:00

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 5 th , 2018 at 4:30 p.m. Eastern Time [...]

Protalix BioTherapeutics to Hold Third Quarter 2018 Financial Results and Corporate Update Conference Call on November 7, 2018

29/10/2018 - 12:00

CARMIEL, Israel, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]

Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study

29/10/2018 - 12:00

Top line results showed larazotide having a significant effect on intestinal permeability, a mechanism thought to be key for bacterial translocation leading to NAFLD/NASH Further preclinical data in combination with [...]

Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit 2018

29/10/2018 - 12:00

NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that it will be presenting findings and retrospective analyses from the Phase 3 HONOR study and [...]

RedHill Biopharma to Host Analyst and Investor Webcast on TALICIA® for H. pylori infection on October 30, 2018

29/10/2018 - 12:00

Top-line results from the ERADICATE Hp2 confirmatory Phase III study expected before year-end 2018 H. pylori bacterial infection affects over 50% of the adult population worldwide and 30-40% of the U.S. population TEL- [...]

Amicus Therapeutics to Announce Third Quarter 2018 Financial Results on November 5, 2018

29/10/2018 - 12:00

CRANBURY, N.J., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, November 5, 2018 at 8:30 a.m. ET to [...]

Vical Reports Third Quarter 2018 Financial and Operational Results

29/10/2018 - 11:30

SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended September 30, 2018. Net loss for the third quarter of 2018 was $1.5 million, or $ [...]

Transactions under Novozymes’ stock buyback program

29/10/2018 - 11:04

Please read the full announcement in the attached PDF Attachment 2018_61_Stock_Buybackprogram_EN

AC Immune Partner Life Molecular Imaging Presents New Clinical Study Results for Tau PET-Tracer 18F-PI-2620

29/10/2018 - 11:01

Study confirms the good performance of tau PET-tracer 18 F-PI-2620 in detecting and quantifying tau deposition, a key pathological feature of Alzheimer's disease Results presented at the 11 th Clinical Trials on [...]

Dynavax to Host Third Quarter 2018 Financial Results Conference Call

29/10/2018 - 11:00

BERKELEY, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will report financial results for the third quarter ended September 30, 2018 after market close [...]

AC Immune SA: New Data Supporting Crenezumab as Potential Alzheimer's Therapy

29/10/2018 - 10:00

Studies show that crenezumab protects neurons from Alzheimer's disease pathologies in vitro and further support the clinical rationale for crenezumab as a potential treatment for Alzheimer's disease Study on PET [...]